M&A Deal Summary

Healiva Acquires B. Braun Medical - Critical Cell Therapy Manufacturing Assets

On November 21, 2022, Healiva acquired life science company B. Braun Medical - Critical Cell Therapy Manufacturing Assets from B. Braun Medical SAS

Acquisition Highlights
  • This is Healiva’s 2nd transaction in the Life Science sector.
  • This is Healiva’s 1st transaction in Switzerland.

M&A Deal Summary

Date 2022-11-21
Target B. Braun Medical - Critical Cell Therapy Manufacturing Assets
Sector Life Science
Buyer(s) Healiva
Sellers(s) B. Braun Medical SAS
Deal Type Divestiture

Target

B. Braun Medical - Critical Cell Therapy Manufacturing Assets

Switzerland
B. Braun Medical's Critical Cell Therapy Manufacturing Assets provides cell therapy products.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Healiva

Lugano, Switzerland

Category Company
Founded 2020
Sector Life Science
DESCRIPTION

Healiva is a patient-centric biotech company delivering life-enhancing precision medicine for patients with chronic and acute wounds. Healiva® creates tailored wound solutions through a multi-pronged approach that combines enzyme technology, medical devices, and cell therapies. Cell therapy describes a process in which viable cells are introduced into the body to produce medicinal effects; cells may be derived from a cell bank (allogeneic cell therapy) or be patient-derived cells converted into the desired cell type or tissue in a lab (autologous cell therapy). Healiva was founded in 2020 and is based in Lugano, Switzerland.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 2 of 2
Country: Switzerland M&A 1 of 1
Year: 2022 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-01 Smith+Nephew - Two Wound-healing Cell Therapy Assets

Watford, United Kingdom

Smith+Nephew - Two Wound-healing Cell Therapy Assets EpiDex®, is an autologous epidermal equivalent that provides a surgery-free approach to healing chronic venous leg ulcers (VLUs). Healiva®002, is an off-the-shelf allogeneic cell therapy that has previously demonstrated clinical efficacy in healing VLUs that are resistant to standard treatments.

Buy -

Seller(S) 1

SELLER

B. Braun Medical SAS

Boulogne-Billancourt, France

Category Company
Sector Distribution
DESCRIPTION

B. Braun Medical SAS is a distributor of medical equipment. B. Braun Medical is based in Boulogne-Billancourt, France.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Switzerland M&A 1 of 1
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-27 Starboard Medical - Clik-FIX Catheter Securement Devices

Irvine, California, United States

Starboard Medical's Clik-FIX Catheter Securement Devices Clik-FIX Peripheral, Clik-FIX PICC/Central, Clik-FIX Universal, Clik-FIX Neonatal PICC & Soft PICC/Central securement device features a soft foam securement base with no hard plastic parts to cause pressure, bruising or trauma to the skin. Starboard Medical's Clik-FIX Catheter Securement Devices is based in Irvine, California.

Buy -